Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 6/20 | 0.69 |
| ▸ | ADORA3 | P0DMS8 | 5/20 | 0.69 |
| ▸ | ADORA2B | P29275 | 4/20 | 0.69 |
| ▸ | ADORA1 | P30542 | 3/20 | 0.69 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.69 |
| ▸ | LMNA | P02545 | 1/20 | 0.66 |
| ▸ | NT5E | P21589 | 1/20 | 0.66 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28774024 | 0.83 | ADORA2A (0.83) | ADORA2AADORA3ADORA2BADORA1LMNA | |
| Acetic Acid SCHEMBL4399000 | 0.82 | ADORA3 (0.72) | ADORA2AADORA3ADORA2BADORA1ADRA1A | |
| SCHEMBL5794230 | 0.82 | ADORA2A (0.67) | ADORA2AADORA3ADORA2BADORA1LMNA | |
| SCHEMBL2343062 | 0.82 | ADORA2A (0.67) | ADORA2AADORA3ADORA2BADORA1LMNA | |
| SCHEMBL7897993 | 0.82 | ADORA2A (0.67) | ADORA2AADORA3ADORA2BADORA1LMNA | |
| Regadenoson Anhydrous SCHEMBL29462353 | 0.82 | ADORA2A (1.00) | ADORA2AADORA3ADORA2BADORA1ADRA1A | |
| Regadenoson Anhydrous SCHEMBL21710782 | 0.82 | ADORA2A (1.00) | ADORA2AADORA3ADORA2BADORA1ADRA1A | |
| SCHEMBL10089232 | 0.82 | ADORA2A (0.71) | ADORA2AADORA3ADORA2BADORA1ADRA1A | |
| Regadenoson Anhydrous SCHEMBL678893 | 0.82 | ADORA2A (1.00) | ADORA2AADORA3ADORA2BADORA1ADRA1A | |
| SCHEMBL11516417 | 0.82 | ADORA2A (0.77) | ADORA2AADORA3ADORA2BADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122070366-A | Cyclic RNA compositions and methods | 欧纳医疗公司 | 2026-05-19 | — | — | CN | disclosed |
| CN-119866376-A | Self-amplifying RNA encoding influenza virus antigen | 辉瑞公司 | 2025-04-22 | — | — | CN | disclosed |